Table 2.
Recipient DSAa | Baseline (N = 80) |
---|---|
DSA overall (class I/II), n = 71b | |
Highest single DSA (MFI), median (range) | 5072.0 (590‐23 365) |
Total DSA (MFI), median (range) | 8159.0 (590‐42 903) |
Total number of DSA, median (range) | 2.0 (1‐6) |
Class I, n = 58 | |
Highest single DSA (MFI), median (range) | 4410.5 (590‐23 365) |
Total DSA (MFI), median (range) | 5854.0 (590‐37 161) |
Total number of DSA, median (range) | 1.0 (1‐4) |
Class II, n = 43 | |
Highest single DSA (MFI), median (range) | 4290.0 (779‐18 126) |
Total DSA (MFI), median (range) | 4654.0 (779‐28 753) |
Total number of DSA, median (range) | 1.0 (1‐4) |
DSA, donor‐specific antibody; MFI, mean fluorescence intensity.
Central laboratory data were confirmatory only and are included for consistency; local laboratory data and historical data were used to evaluate patient eligibility; N = 79 for this variable.
Eight patients had no DSAs at transplant but were included in the study because they had a historical positive crossmatch.